Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 229 to 232 of 232 entries
Sorted by: Best Match Show Resources per page
Variants of human CLDN9 cause mild to profound hearing loss.

Human mutation

Ramzan M, Philippe C, Belyantseva IA, Nakano Y, Fenollar-Ferrer C, Tona R, Yousaf R, Basheer R, Imtiaz A, Faridi R, Munir Z, Idrees H, Salman M, Nambot S, Vitobello A, Kartti S, Zarrik O, Witmer PD, Sobreria N, Ibrahimi A, Banfi B, Moutton S, Friedman TB, Naz S.
PMID: 34265170
Hum Mutat. 2021 Oct;42(10):1321-1335. doi: 10.1002/humu.24260. Epub 2021 Aug 01.

Hereditary deafness is clinically and genetically heterogeneous. We investigated deafness segregating as a recessive trait in two families. Audiological examinations revealed an asymmetric mild to profound hearing loss with childhood or adolescent onset. Exome sequencing of probands identified a...

Cite
Ramzan M, Philippe C, Belyantseva IA, et al. Variants of human CLDN9 cause mild to profound hearing loss. Hum Mutat. 2021;42(10):1321-1335doi: 10.1002/humu.24260.
Ramzan, M., Philippe, C., Belyantseva, I. A., Nakano, Y., Fenollar-Ferrer, C., Tona, R., Yousaf, R., Basheer, R., Imtiaz, A., Faridi, R., Munir, Z., Idrees, H., Salman, M., Nambot, S., Vitobello, A., Kartti, S., Zarrik, O., Witmer, P. D., Sobreria, N., Ibrahimi, A., Banfi, B., Moutton, S., Friedman, T. B., & Naz, S. (2021). Variants of human CLDN9 cause mild to profound hearing loss. Human mutation, 42(10), 1321-1335. https://doi.org/10.1002/humu.24260
Ramzan, Memoona, et al. "Variants of human CLDN9 cause mild to profound hearing loss." Human mutation vol. 42,10 (2021): 1321-1335. doi: https://doi.org/10.1002/humu.24260
Ramzan M, Philippe C, Belyantseva IA, Nakano Y, Fenollar-Ferrer C, Tona R, Yousaf R, Basheer R, Imtiaz A, Faridi R, Munir Z, Idrees H, Salman M, Nambot S, Vitobello A, Kartti S, Zarrik O, Witmer PD, Sobreria N, Ibrahimi A, Banfi B, Moutton S, Friedman TB, Naz S. Variants of human CLDN9 cause mild to profound hearing loss. Hum Mutat. 2021 Oct;42(10):1321-1335. doi: 10.1002/humu.24260. Epub 2021 Aug 01. PMID: 34265170; PMCID: PMC8435009.
Copy Download .nbib Format: NLM
Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants.

Occupational and environmental medicine

Mutambudzi M, Niedwiedz C, Macdonald EB, Leyland A, Mair F, Anderson J, Celis-Morales C, Cleland J, Forbes J, Gill J, Hastie C, Ho F, Jani B, Mackay DF, Nicholl B, O'Donnell C, Sattar N, Welsh P, Pell JP, Katikireddi SV, Demou E.
PMID: 33298533
Occup Environ Med. 2020 Dec 09; doi: 10.1136/oemed-2020-106731. Epub 2020 Dec 09.

OBJECTIVES: To investigate severe COVID-19 risk by occupational group.METHODS: Baseline UK Biobank data (2006-10) for England were linked to SARS-CoV-2 test results from Public Health England (16 March to 26 July 2020). Included participants were employed or self-employed at...

Cite
Mutambudzi M, Niedwiedz C, Macdonald EB, et al. Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants. Occup Environ Med. 2020;doi: 10.1136/oemed-2020-106731.
Mutambudzi, M., Niedwiedz, C., Macdonald, E. B., Leyland, A., Mair, F., Anderson, J., Celis-Morales, C., Cleland, J., Forbes, J., Gill, J., Hastie, C., Ho, F., Jani, B., Mackay, D. F., Nicholl, B., O'Donnell, C., Sattar, N., Welsh, P., Pell, J. P., Katikireddi, S. V., & Demou, E. (2020). Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants. Occupational and environmental medicine, . https://doi.org/10.1136/oemed-2020-106731
Mutambudzi, Miriam, et al. "Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants." Occupational and environmental medicine vol. (2020). doi: https://doi.org/10.1136/oemed-2020-106731
Mutambudzi M, Niedwiedz C, Macdonald EB, Leyland A, Mair F, Anderson J, Celis-Morales C, Cleland J, Forbes J, Gill J, Hastie C, Ho F, Jani B, Mackay DF, Nicholl B, O'Donnell C, Sattar N, Welsh P, Pell JP, Katikireddi SV, Demou E. Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants. Occup Environ Med. 2020 Dec 09; doi: 10.1136/oemed-2020-106731. Epub 2020 Dec 09. PMID: 33298533; PMCID: PMC7611715.
Copy Download .nbib Format: NLM
Huge carbuncle leading to necrotizing fasciitis in the COVID-19 pandemic era.

Clinical case reports

Gheisari M, Baghani M, Ganji R, Forouzanfar MM.
PMID: 33768893
Clin Case Rep. 2021 Jan 28;9(3):1583-1586. doi: 10.1002/ccr3.3839. eCollection 2021 Mar.

Although Necrotizing fasciitis can evolve from a trivial lesion, whenever it develops it requires a prompt surgical intervention and broad-spectrum antibiotic therapy.

Cite
Gheisari M, Baghani M, Ganji R, et al. Huge carbuncle leading to necrotizing fasciitis in the COVID-19 pandemic era. Clin Case Rep. 2021;9(3):1583-1586doi: 10.1002/ccr3.3839.
Gheisari, M., Baghani, M., Ganji, R., & Forouzanfar, M. M. (2021). Huge carbuncle leading to necrotizing fasciitis in the COVID-19 pandemic era. Clinical case reports, 9(3), 1583-1586. https://doi.org/10.1002/ccr3.3839
Gheisari, Mehdi, et al. "Huge carbuncle leading to necrotizing fasciitis in the COVID-19 pandemic era." Clinical case reports vol. 9,3 (2021): 1583-1586. doi: https://doi.org/10.1002/ccr3.3839
Gheisari M, Baghani M, Ganji R, Forouzanfar MM. Huge carbuncle leading to necrotizing fasciitis in the COVID-19 pandemic era. Clin Case Rep. 2021 Jan 28;9(3):1583-1586. doi: 10.1002/ccr3.3839. eCollection 2021 Mar. PMID: 33768893; PMCID: PMC7981722.
Copy Download .nbib Format: NLM
A Randomized Clinical Trial of Intratracheal Administration of Surfactant and Budesonide Combination in Comparison to Surfactant for Prevention of Bronchopulmonary Dysplasia.

Oman medical journal

Gharehbaghi MM, Ganji S, Mahallei M.
PMID: 34447583
Oman Med J. 2021 Jul 31;36(4):e289. doi: 10.5001/omj.2021.84. eCollection 2021 Jul.

OBJECTIVES: Bronchopulmonary dysplasia (BPD) remains a major problem in preterm infants occurring in up to 50% of infants born at < 28 weeks gestational age. Inflammation plays an important role in the pathogenesis of BPD. This study was conducted...

Cite
Gharehbaghi MM, Ganji S, Mahallei M. A Randomized Clinical Trial of Intratracheal Administration of Surfactant and Budesonide Combination in Comparison to Surfactant for Prevention of Bronchopulmonary Dysplasia. Oman Med J. 2021;36(4):e289doi: 10.5001/omj.2021.84.
Gharehbaghi, M. M., Ganji, S., & Mahallei, M. (2021). A Randomized Clinical Trial of Intratracheal Administration of Surfactant and Budesonide Combination in Comparison to Surfactant for Prevention of Bronchopulmonary Dysplasia. Oman medical journal, 36(4), e289. https://doi.org/10.5001/omj.2021.84
Gharehbaghi, Manizheh M, et al. "A Randomized Clinical Trial of Intratracheal Administration of Surfactant and Budesonide Combination in Comparison to Surfactant for Prevention of Bronchopulmonary Dysplasia." Oman medical journal vol. 36,4 (2021): e289. doi: https://doi.org/10.5001/omj.2021.84
Gharehbaghi MM, Ganji S, Mahallei M. A Randomized Clinical Trial of Intratracheal Administration of Surfactant and Budesonide Combination in Comparison to Surfactant for Prevention of Bronchopulmonary Dysplasia. Oman Med J. 2021 Jul 31;36(4):e289. doi: 10.5001/omj.2021.84. eCollection 2021 Jul. PMID: 34447583; PMCID: PMC8376750.
Copy Download .nbib Format: NLM
Showing 229 to 232 of 232 entries